Skip to content
Disclosery

Adamant Biomedical Investments AG: THC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Adamant Biomedical Investments AG on THC, newest first. How the timeline and the estimate are built.

Adamant Biomedical Investments AG held 35,000 THC shares at 2014-12-31 per its 13F-HR filed 2015-02-13.

the latest 13F is the newest step

  1. period ended2014-12-31
    13F 35,000 shares
    Change vs previous 13F not available

    0.42% of the 13F portfolio, value $1,773,000.

    13F-HR 0000950123-15-002090 filed by Adamant Biomedical Investments AG
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec ยง4.2).